SGHT — Sight Sciences Income Statement
0.000.00%
- $378.65m
- $285.06m
- $81.06m
- 63
- 19
- 78
- 52
Annual income statement for Sight Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 23.3 | 27.6 | 49 | 71.3 | 81.1 |
Cost of Revenue | |||||
Gross Profit | 16.8 | 18.4 | 40.3 | 59 | 69.2 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 47.4 | 59.8 | 100 | 155 | 138 |
Operating Profit | -24 | -32.2 | -51.5 | -84 | -57.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -25.9 | -34.6 | -62.8 | -86.2 | -55.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -25.9 | -34.7 | -63 | -86.2 | -55.5 |
Net Income Before Extraordinary Items | |||||
Net Income | -25.9 | -34.7 | -63 | -86.2 | -55.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -25.9 | -34.7 | -63 | -86.2 | -55.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.574 | -0.77 | -2.36 | -1.8 | -1.14 |